Search Results - "Shitrit, A"

Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab by Ungar, B., Kopylov, U., Engel, T., Yavzori, M., Fudim, E., Picard, O., Lang, A., Williet, N., Paul, S., Chowers, Y., Bar‐Gil Shitrit, A., Eliakim, R., Ben‐Horin, S., Roblin, X.

“…Summary Background Anti‐adalimumab antibodies (AAA) are associated with loss of clinical response (LOR). Addition of an immunomodulator has been shown to…”
Get full text

Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic by De Lima-Karagiannis, A, Juillerat, P, Sebastian, S, Pedersen, N, Bar-Gil Shitrit, A, van der Woude, C J

“…Abstract The rapid emergence of the novel coronavirus [SARS-CoV2] and the coronavirus disease 2019 [COVID-19] has caused significant global morbidity and…”
Get full text

Tricyclic antidepressants for the treatment of tenesmus associated with rectal prolapse by Livovsky, D. M., Adler, S. N., Adar, T., Bar‐Gil Shitrit, A., Lysy, J.

“…Aim Tenesmus in rectal prolapse leads to a vicious circle of straining with deterioration of prolapse. The primary phenomenon triggering this may be rectal…”
Get full text

P157 DIFFERENTIAL TH17 PROFILE WITHIN THE PORTAL VEIN COMPARED TO SYSTEMIC CIRCULATION – A PROOF OF CONCEPT FOR DEFINING THE PORTAL VEIN AS A DISCRETE IMMUNOLOGICAL COMPARTMENT by Adar, T, Shteingart, S, Edden, Y, Mahamid, M, Broide, E, Bar-Gil Shitrit, A, Goldin, E

Get full text

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study by Chaparro, M, Verreth, A, Lobaton, T, Gravito-Soares, E, Julsgaard, M, Savarino, E, Magro, F, Biron, Avni I, Lopez-Serrano, P, Casanova, M J, Gompertz, M, Vitor, S, Arroyo, M, Pugliese, D, Zabana, Y, Vicente, R, Aguas, M, Shitrit, Bar-Gil A, Gutierrez, A, Doherty, G A, Fernandez-Salazar, L, Cadilla, Martínez J, Huguet, J M, OʼToole, A, Stasi, E, Marcos, Manceñido N, Villoria, A, Karmiris, K, Rahier, J F, Rodriguez, C, Palomares, Diz-Lois M, Fiorino, G, Benitez, J M, Principi, M, Naftali, T, Taxonera, C, Mantzaris, G, Sebkova, L, Iade, B, Lissner, D, Bradley, Ferrer I, Roman, Lopez-San A, Marin-Jimenez, I, Merino, O, Sierra, M, Van Domselaar, M, Caprioli, F, Guerra, I, Peixe, P, Piqueras, M, Rodriguez-Lago, I, Ber, Y, van Hoeve, K, Torres, P, Gravito-Soares, M, Rudbeck-Resdal, D, Bartolo, O, Peixoto, A, Martin, G, Armuzzi, A, Garre, A, Donday, M G, de Carpi, Martín F J, Gisbert, J P

“…The long-term safety of exposure to anti-tumor necrosis factor (anti-TNFα) drugs during pregnancy has received little attention. We aimed to compare the…”
Get full text

G protein coupled receptors -in silico drug discovery and design by Sela, I, Golan, G, Strajbl, M, Rivenzon-Segal, D, Bar-Haim, S, Bloch, I, Inbal, B, Shitrit, A, Ben-Zeev, E, Fichman, M, Markus, Y, Marantz, Y, Senderowitz, H, Kalid, O

“…In silico drug discovery is a complex process requiring flexibility and ingenuity in method selection and a careful validation of work protocols. GPCR in…”
Get more information

Splenic infarction: an unusual complication of ethanolamine oleate injection by Bar-Gil Shitrit, A, Aharoni, D, Zeides, S, Braverman, D

Get more information

Normal D-dimer levels in patients with latent tuberculosis infection by Shitrit, D, Izbicki, G, Shitrit, A Bar-Gil, Raz, M, Sulkes, J, Kramer, M R

“…Studies have demonstrated a link between acute pulmonary tuberculosis and a hypercoagulable state, but there are no data on the coagulation state of patients…”
Get full text

P519 Assessment of anal sphincter complex in pregnant patients with non-active perianal Crohns disease by Bar-Gil Shitrit, A, Mishael, T, Reiss Mintz, H, Goldenberg, R, Freund, M R, Yellinek, S

“…Abstract Background Pregnant IBD patients are more likely to undergo Cesarean delivery (CS).. Active perianal Crohn’s disease (PCD) is the only Crohns -…”
Get full text

1789P The gamma secretase inhibitor AL101 combined with other drugs for dual targeting of Notch dysregulated tumors by Ferrarotto, R., Rauch, R., Leibovich, T., Shitrit, A., Solomon, O., Herz, E., Walker, R.M., Ho, A.L., Kaye, J.

Get full text

Appropriate indications for venous duplex scanning based on D-dimer assay by Shitrit, D, Levi, H, Huerta, M, Rudensky, B, Bargil-Shitrit, A, Gutterer, N

“…Because of the rapid growth in requests for lower extremity duplex scanning, we tested a new rapid D-dimer assay method, the Miniquant test, for its ability to…”
Get more information

P909 Microbiome dynamics leading up to and during pregnancy in a matched IBD-control cohort by Binyamin, D, Turjeman, S, Koren, O, Ben Ya'acov, A, Gold, G, Goldenberg, R, Bar-Gil Shitrit, A

“…Abstract Background A common feature of inflammatory bowel diseases (IBD) is dysbiosis of gut microbiota. IBD usually affects women during their childbearing…”
Get full text

P552 Gastroenterologists’ perceptions on use of medical cannabis for IBD by Koslowsky, B, Bar-Gil Shitrit, A, Goldin, E, Mazuz, B

“…Abstract Background The use of medical cannabis (MC) for numerous medical indications is expanding. Current evidence does not support the efficacy of MC for…”
Get full text

Hyperinsulinemia: a link between hypertension obesity and glucose intolerance by MODAN, M, HALKIN, H, ALMOG, S, LUSKY, A, ESHKOL, A, SHEFI, M, SHITRIT, A, FUCHS, Z

Get full text

P663 Efficacy of jak inhibitors in inflammatory bowel disease patients with extraintestinal manifestations– Retrospective study by Livne Margolin, M, González Lama2, Y, Koutroubakis, I, Drygiannakis, I, Shitrit, A, Goldenberg, R, Farkas, K, Molnar, T, Ivány, E, Amiot, A, Carbonnel, F, Girod, P, Doherty, G, Mateescu, B, Ben-Horin1, S, Kopylov, U

“…Abstract Background JAK inhibitors have demonstrated efficacy in ulcerative colitis (UC), Crohn’s disease (CD), and inflammatory arthritis. However, limited…”
Get full text

P635 Risankizumab - real world Israeli data in severe refractory IBD patients by Bar-Gil Shitrit, A, Gil, Y, Israeli, E, Koslowsky, B, Mazuz, B, Israel, I, Goldenberg, R, Ben-Bassat, O, Weisbrud, A, Ledder, O, Zinger, A, Ben Horin, S, Goldin, E, Lahat, A

“…Abstract Background The landscape of inflammatory bowel disease (IBD) treatment is rapidly expanding with the development of new therapeutic options…”
Get full text

N818 A specialized IBD unit infusion center is preferred by patients by Koslowsky, B., Mazuz, B., Goldin, E., Bar-Gil Shitrit, A.

Get full text

P307 Fecal Lactoferrin levels are stable during pregnancy by Koslowsky, B., Livovsky, D.M., Goldin, E., Bar-Gil Shitrit, A.

Get full text

P155 Clinical utility of fecal calprotectin in monitoring disease activity and predicting relapse in pregnant patients with inflammatory bowel diseases by Amihai, R, Mishael, T, Grisaru-Granovski, S, Koslowsky, B, Abitbol, G, Goldin, E, Bar-Gil Shitrit, A

“…Abstract Background Inflammatory bowel diseases (IBDs) are commonly diagnosed in reproductive-aged women and can substantially affect pregnancy outcomes…”
Get full text

P242 Prior pregnancy outcome is an important determinant of subsequent pregnancy outcome in women with inflammatory bowel diseases by Rottenstreich, A, Fridman Lev, S, Rotem, R, Mishael, T, Koslowsky, B, Goldin, E, Grisaru-Granovsky, S, Bar-Gil Shitrit, A

“…Abstract Background Inflammatory bowel diseases (IBD) are commonly diagnosed in women of childbearing age. As such, pregnancy is often encountered in this…”
Get full text